Evidence map›Paper›PMID 42626305›Full record

ReviewExperimental and therapeutic medicine2026

Advances in new ultrasound technologies in targeted prostate biopsy (Review).

Tingting Jin, Liying Wang, Shusen Zheng

Abstract readReview
In one paragraph

Review in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tingting JinDepartment of Ultrasound, Shaoxing Second Hospital, Shaoxing, Zhejiang 312000, P.R. China.
Liying WangDepartment of Ultrasound, Shaoxing Second Hospital, Shaoxing, Zhejiang 312000, P.R. China.
Shusen ZhengKey Laboratory of Combined Multi-Organ Transplantation, Ministry of Public Health, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transrectal ultrasound-guided systematic biopsy is the standard method for diagnosing prostate cancer (PCa). As the inherent randomness of systematic biopsy results in a relatively high rate of missed diagnoses, targeted biopsy techniques guided by advanced ultrasound technologies, such as micro-ultrasound, contrast-enhanced ultrasound, ultrasound elastography and resonance-ultrasound fusion imaging, can markedly enhance the detection of clinically significant PCa and represent promising applications in prostate biopsy. The present review summarizes targeted prostate biopsy guided by new ultrasound technologies.

Indexed as

biopsyCEUSelastographymagnetic resonance imagingprostateultrasound

Identifiers

PMID42626305
PMCPMC13492040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.